The guidelines of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases recommend optimal management of heart failure and arrhythmias caused by myocarditis, including the use of diuretics, ACE inhibitors, beta-adrenergic blockade, antiarrhythmics, and temporary stimulation [114]. This evidence concerns the gene ACE and Arrhythmia.